Glycopyrrolate Injection
Product Images NDC 70756-632

12 FDA label images from Lifestar Pharma Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 70756-632). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pic (19408a9d 222f 42e1 B28a 801178b0f5f3 01)

Pic (19408a9d 222f 42e1 B28a 801178b0f5f3 01)
Chemical structure of glycopyrrolate, depicting its molecular components including a pyrrolidinium ring, phenyl group, hydroxyl group, ester linkage, and bromide ion.*
FDA Label Image

0.2 (19408a9d 222f 42e1 B28a 801178b0f5f3 02)

0.2 (19408a9d 222f 42e1 B28a 801178b0f5f3 02)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL, a human prescription drug in solution form for intramuscular or intravenous use. The label specifies a 1 mL single dose vial containing benzyl alcohol. Manufactured for Lifestar Pharma LLC, this product is made in India.*
FDA Label Image

0.2 mg 5x1 (19408a9d 222f 42e1 B28a 801178b0f5f3 03)

0.2 mg 5x1 (19408a9d 222f 42e1 B28a 801178b0f5f3 03)
The packaging label for Glycopyrrolate Injection, USP displays a concentration of 0.2 mg/mL. It is intended for intramuscular or intravenous administration and contains 5 single-dose vials of 1 mL each. The label highlights that the product contains benzyl alcohol and is not for use in newborns. Lifestar Pharma LLC is the labeler, with manufacturing noted in India. Storage instructions specify controlled room temperature of 20°C to 25°C (68°F to 77°F).*
FDA Label Image

0.2 Carrton (19408a9d 222f 42e1 B28a 801178b0f5f3 04)

0.2 Carrton (19408a9d 222f 42e1 B28a 801178b0f5f3 04)
Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL from Lifestar Pharma LLC. This human prescription drug is supplied in 25 single-dose 1 mL vials for intramuscular or intravenous administration. The label includes storage instructions, a warning that it contains benzyl alcohol and is not for use in newborns, as well as manufacturer information.*
FDA Label Image

0.4mg/2 mL (19408a9d 222f 42e1 B28a 801178b0f5f3 05)

0.4mg/2 mL (19408a9d 222f 42e1 B28a 801178b0f5f3 05)
Label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) single dose vial by Lifestar Pharma LLC. The injection contains benzyl alcohol and is for intramuscular or intravenous use. The label includes dosage, manufacturer info, barcodes, and handling instructions.*
FDA Label Image

0.4mg-2ml (19408a9d 222f 42e1 B28a 801178b0f5f3 06)

0.4mg-2ml (19408a9d 222f 42e1 B28a 801178b0f5f3 06)
Packaging label for Glycopyrrolate Injection, USP 0.2 mg/mL (0.4 mg/2 mL) by Lifestar Pharma LLC. The label states the product is for intramuscular or intravenous administration in 25 vials of 2 mL single dose. It includes warnings such as not for use in newborns and contains benzyl alcohol. Manufactured by Lifestar Pharma LLC, Mahwah, NJ, and made in India.*
FDA Label Image

1 mg-5ml (19408a9d 222f 42e1 B28a 801178b0f5f3 07)

1 mg-5ml (19408a9d 222f 42e1 B28a 801178b0f5f3 07)
Label for Glycopyrrolate Injection, USP, 1 mg/5 mL (0.2 mg/mL) injection. The label indicates it is for intramuscular or intravenous administration, contains benzyl alcohol, and is not for use in newborns. It is a 5 mL multiple dose vial manufactured by Lifestar Pharma LLC, with storage instructions at controlled room temperature. The label includes barcodes and manufacturing information.*
FDA Label Image

1 mg 5 mL 10x5 (19408a9d 222f 42e1 B28a 801178b0f5f3 08)

1 mg 5 mL 10x5 (19408a9d 222f 42e1 B28a 801178b0f5f3 08)
Carton packaging label for Glycopyrrolate Injection, USP, 1 mg/mL (0.2 mg/mL), a multiple dose injection vial. The label states it is for intramuscular or intravenous administration, contains benzyl alcohol, and is not for use in newborns. The labeler is Lifestar Pharma LLC, with manufacturing in India. The package contains 10 x 5 mL vials.*
FDA Label Image

1 mg- 5ml (19408a9d 222f 42e1 B28a 801178b0f5f3 09)

1 mg- 5ml (19408a9d 222f 42e1 B28a 801178b0f5f3 09)
Packaging label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) injection, for intramuscular or intravenous use. The label notes it contains benzyl alcohol, is not for use in newborns, and is supplied as 25 x 5 mL multiple dose vials. Manufactured for Lifestar Pharma LLC, made in India.*
FDA Label Image

4 mg- 20 mL (19408a9d 222f 42e1 B28a 801178b0f5f3 10)

4 mg- 20 mL (19408a9d 222f 42e1 B28a 801178b0f5f3 10)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL (4 mg/20 mL) in a 20 mL multiple dose vial. The solution contains benzyl alcohol and is for intramuscular or intravenous administration. Manufactured for Lifestar Pharma LLC. The label includes storage instructions and barcodes.*
FDA Label Image

4 mg-20 mL (19408a9d 222f 42e1 B28a 801178b0f5f3 11)

4 mg-20 mL (19408a9d 222f 42e1 B28a 801178b0f5f3 11)
Packaging label for Glycopyrrolate Injection, USP, 4 mg/20 mL (0.2 mg/mL) intramuscular and intravenous injection. The label indicates multiple dose vials, 10 x 20 mL, containing Benzyl Alcohol as a preservative. Manufactured for Lifestar Pharma LLC and includes storage instructions and dosage guidance reference.*
FDA Label Image

4 mg 20 mL 25x20 (19408a9d 222f 42e1 B28a 801178b0f5f3 12)

4 mg 20 mL 25x20 (19408a9d 222f 42e1 B28a 801178b0f5f3 12)
Label for Glycopyrrolate Injection, USP 0.2 mg/mL (4 mg/20 mL) by Lifestar Pharma LLC. The label indicates the drug is for intramuscular or intravenous administration, contains benzyl alcohol as a preservative, and comes in a 25 x 20 mL multiple-dose vial. It is labeled for prescription use and notes it is not for use in newborns.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.